Jefferies Upgrades BioMed Realty (BMR) to Buy

Article Stock Quotes (1) Comments (0)

Jefferies upgraded BioMed Realty (NYSE: BMR) from Hold to Buy and raised their price target from $19 to $23.

The firm said, "We recommend adding stocks in defensive sectors, but which have offensive characteristics, strong earnings growth, and attractive valuations."

For more ratings news on BioMed Realty click here and for the rating history of BioMed Realty click here.

Shares of BioMed Realty closed at $19.51 yesterday, with a 52 week range of $15.84-$20.86.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
• RBC Capital Upgrades Pandora (P) to Outperform
• Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold

Create E-mail Alert Related Categories

Upgrades

Related Entities

Jefferies & Co, Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?